Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPH Therapeutics is a clinical-stage biopharmaceutical company and a core R&D subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company focuses on the discovery and development of innovative therapies for oncology, autoimmune disorders, and metabolic diseases. Leveraging the extensive resources of its parent group, SPH Therapeutics manages a diverse pipeline of small molecules and biologics, with several candidates currently in Phase 1 and Phase 2 clinical trials. The company aims to address significant unmet medical needs in China and global markets through both internal research and strategic external collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPH Therapeutics.